Cephalexin Completed Phase 3 Trials for Arrythmias Prevention

IndicationsStatusPurposePhase
CompletedPrevention3
clinicaltrials.gov IdentifierTitleDrugs
NCT01002911Prevention of Arrhythmia Device Infection Trial (PADIT Pilot)